Research Article
Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy in the Treatment of Oral Vascular Malformations
Table 2
Details of comparison between diode laser and sclerotherapy.
| Details of site of involvement | | Laser group | STS group | Chi sq 2.424 value 0.658NS | Tongue | 9 (45%) | 9 (45%) | Buccal mucosa | 5 (25%) | 6 (30%) | Lower labial mucosa | 3 (15%) | 3 (15%) | Upper labial mucosa | 1 (5%) | 2 (10%) | Palate | 2 (10%) | 0 | Total | 20 (100%) | 20 (100%) |
| Details of size of involvement | Less than cm | 8 (40%) | 7 (35%) | Chi sq 0.722 value 0.715NS | cm- cm | 6 (30%) | 4 (20%) | cm- cm | 4 (20%) | 4 (20%) | More than 3.1 cm | 2 (10%) | 5 (25%) | Total | 20(100%) | 20 (100%) |
| Details of the number of session | 1 session | 10 (50%) | 12 (60%) | Chi sq 1.143 value 0.565NS | 2 session | 7 (35%) | 4 (20%) | 3 or more than 3 session | 3 (15%) | 4 (20%) | Total | 20 (100%) | 20 (100%) |
| Details of the side effects | Pain | 15 (75%) | 20 (100%) | Chi sq 4.051 value 0.044 | Edema | 0 | 20 (100%) | Superficial ulceration | 20 (100%) | 20 (100%) | Mild ecchymosis | 0 | 1 (5%) |
| Details of the VAS scale on 3rd postoperative day | 7-10 VAS | 0 | 14 (70%) | Chi sq 29.091 value < 0.001 | 4-6 VAS | 5 (25%) | 6 (30%) | 1-4 VAS | 10 (50%) | 0 | 0 VAS/no pain | 5 (25%) | 0 | Total | 20 (100%) | 20 (100%) |
| Response of treatment to individual groups | Complete response | 16 (80%) | 18 (90%) | Chi sq 0.784 value 0.376NS | Moderate response | 4 (20%) | 2 (10%) | No response | 0 | 0 | Total | 20 (100%) | 20 (100%) |
| Details of the recurrences | Recurrences | 5 (25%) | 1 (5%) | — | Total | 20 (100%) | 20 (100%) |
|
|